中国严重喘的管理和研究进展
Xiaoying Chen1,2, Rui Feng1,2, Xiaolong Ji1,2
1State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, Joint International Research Laboratory of Respiratory Health, Guangdong Basic Research Center of Excellence for Respiratory Medicine, Department of Allergy and Clinical Immunology, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
严重的喘影响全球数以百万计的人,在中国也面临着挑战. 最近了解其原因的进展和生物疗法的发展为这种复杂的呼吸系统疾病提供了新的治疗策略.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 喘是一种常见的慢性呼吸道疾病,影响全球3亿人.
- 严重的喘无法通过标准疗法控制,造成严重的健康和经济负担,特别是在中国 (患病率为3.4%-8.3%).
- 这种情况的特点是异质性和频繁的恶化.
研究的目的:
- 审查中国关于严重喘的近期进展情况.
- 讨论严重喘的流行病学,病变发生和生物治疗.
主要方法:
- 文献综述专注于最近的中国研究.
- 对流行病学数据,病原遗传机制和生物治疗进展的分析.
主要成果:
- 严重的喘在中国表现出显著的异质性和负担.
- 生物药物在治疗严重喘方面是一个有前途的前沿.
结论:
- 了解严重喘的发病因子对于开发向治疗至关重要.
- 生物治疗正在成为中国严重喘管理的关键策略.
相关概念视频
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management
First, in...
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
COPD: Management Using Bronchodilators and Corticosteroids


